Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Akari Therapeutics Plc (AKTX)

1.86   -0.04 (-2.11%) 07-15 16:00
Open: 1.88 Pre. Close: 1.9
High: 1.89 Low: 1.8601
Volume: 49,942 Market Cap: 31M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.893 - 1.906 1.906 - 1.916
Low: 1.825 - 1.843 1.843 - 1.857
Close: 1.835 - 1.859 1.859 - 1.878

Technical analysis

as of: 2019-07-15 4:40:09 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 2.79     One year: 3.25
Support: Support1: 1.75    Support2: 1.46
Resistance: Resistance1: 2.39    Resistance2: 2.78
Pivot: 2.01
Moving Average: MA(5): 1.94     MA(20): 2.05
MA(100): 2.77     MA(250): 2.25
MACD: MACD(12,26): -0.11     Signal(9): -0.12
Stochastic oscillator: %K(14,3): 32.39     %D(3): 30.56
RSI: RSI(14): 34.91
52-week: High: 9.20  Low: 1.56  Change(%): -13.9
Average Vol(K): 3-Month: 61857  10-Days: 9108

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
AKTX has closed below the lower band by 2.4%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 80.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to AKTX's normal range. The bands have been in this narrow range for 23 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 04 Jul 2019 14:45:41 Z
Alexion's Ultomiris Receives EU Approval for PNH in Adults

Fri, 28 Jun 2019 15:22:38 Z
Alexion Receives FDA Approval for Label Expansion of Soliris

Fri, 21 Jun 2019 17:34:25 Z
Alexion's sBLA for Ultomiris Gets Priority Review From FDA

Thu, 20 Jun 2019 15:38:30 Z
Akari (AKTX) Eye Candidate Proves Safety in Early-Stage Study

Mon, 04 Feb 2019 20:08:21 Z
Alexion's (ALXN) Earnings Beat Estimates in Q4, Shares Up

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 15.86
Shares Float (M) 9.28
% Held by Insiders 57.08
% Held by Institutions 5.55
Shares Short (K) 64
Shares Short P. Month (K)

Stock Financials

EPS -1.137
EPS Est. Current Year -2.360
EPS Est. Next Year -3.110
EPS Est. Next Quarter -0.660
Forward EPS -1.938
Book Value (p.s.) 0.080
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -66.9
Return on Equity (ttm) -201.5
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -1.156
Qtrly Earnings Growth
Operating Cash Flow (M) -17.95
Levered Free Cash Flow (M) -12.35

Stock Valuations

P/E -1.64
P/E Growth Ratio -0.02
P/BV 23.25
P/CF -1.64

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-09-17
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.